cusman

Crocs: It's the Product, Not the Economy

Seems to me that the Medicare endorsement for Crox shoes for Diabetics is an automatic boon to their sales base. About 22 million pairs more shoes to sell.

Also Crox has growth overseas in europe and is expanding to other markets.

Their US retails sales growth has stagnated or declined doesn't mean the company is dead.

I wonder why this company was trading at $70/share just a year ago and now at $5 it is not considered under-valued?